165 related articles for article (PubMed ID: 26947960)
21. The role of the pathologist and clinical implications in colorectal liver metastasis.
Baldin P; Van den Eynde M; Hubert C; Jouret-Mourin A; Komuta M
Acta Gastroenterol Belg; 2018; 81(3):419-426. PubMed ID: 30350532
[TBL] [Abstract][Full Text] [Related]
22. Preoperative Chemotherapy with Bevacizumab Extends Disease-free Survival After Resection of Liver Metastases from Colorectal Cancer.
Umehara M; Umehara Y; Takahashi K; Murata A; Nishikawa S; Tokura T; Matsuzaka M; Tanaka R; Morita T
Anticancer Res; 2016 Apr; 36(4):1949-54. PubMed ID: 27069185
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
[TBL] [Abstract][Full Text] [Related]
24. Bevacizumab protects against sinusoidal obstruction syndrome and does not increase response rate in neoadjuvant XELOX/FOLFOX therapy of colorectal cancer liver metastases.
Klinger M; Eipeldauer S; Hacker S; Herberger B; Tamandl D; Dorfmeister M; Koelblinger C; Gruenberger B; Gruenberger T
Eur J Surg Oncol; 2009 May; 35(5):515-20. PubMed ID: 19200687
[TBL] [Abstract][Full Text] [Related]
25. Extracapsular lymph node involvement is associated with colorectal liver metastases and impact outcome after hepatectomy for colorectal metastases.
Suzuki H; Fujii T; Asao T; Tsutsumi S; Wada S; Araki K; Kubo N; Watanabe A; Tsukagoshi M; Kuwano H
World J Surg; 2014 Aug; 38(8):2079-88. PubMed ID: 24615606
[TBL] [Abstract][Full Text] [Related]
26. A reversal in the vascularity of metastatic liver tumors from colorectal cancer after the cessation of chemotherapy plus bevacizumab: contrast-enhanced ultrasonography and histological examination.
Kitamura H; Koike S; Nakazawa K; Matsumura H; Yokoi K; Nakagawa K; Arai M
J Surg Oncol; 2013 Feb; 107(2):155-9. PubMed ID: 22903532
[TBL] [Abstract][Full Text] [Related]
27. Prognostic impact of immune response in resectable colorectal liver metastases treated by surgery alone or surgery with perioperative FOLFOX in the randomised EORTC study 40983.
Tanis E; Julié C; Emile JF; Mauer M; Nordlinger B; Aust D; Roth A; Lutz MP; Gruenberger T; Wrba F; Sorbye H; Bechstein W; Schlag P; Fisseler A; Ruers T
Eur J Cancer; 2015 Nov; 51(17):2708-17. PubMed ID: 26342674
[TBL] [Abstract][Full Text] [Related]
28. Prognostic impact of margin status in liver resections for colorectal metastases after bevacizumab.
Sasaki K; Margonis GA; Andreatos N; Wilson A; Weiss M; Wolfgang C; Sergentanis TN; Polychronidis G; He J; Pawlik TM
Br J Surg; 2017 Jun; 104(7):926-935. PubMed ID: 28266705
[TBL] [Abstract][Full Text] [Related]
29. Surgery after neoadjuvant chemotherapy for colorectal liver metastases is safe and feasible in elderly patients.
Tamandl D; Gruenberger B; Herberger B; Kaczirek K; Gruenberger T
J Surg Oncol; 2009 Oct; 100(5):364-71. PubMed ID: 19235181
[TBL] [Abstract][Full Text] [Related]
30. Repeat hepatectomy with systemic chemotherapy might improve survival of recurrent liver metastasis from colorectal cancer-a retrospective observational study.
Matsuoka H; Morise Z; Tanaka C; Hayashi T; Ikeda Y; Maeda K; Masumori K; Koide Y; Katsuno H; Tanahashi Y; Nakajima S; Hanai T; Kato Y; Sugioka A; Uyama I
World J Surg Oncol; 2019 Feb; 17(1):33. PubMed ID: 30770753
[TBL] [Abstract][Full Text] [Related]
31. Outcome of metastatic colorectal cancer: analysis of a consecutive series of 229 patients. The impact of a multidisciplinary approach.
Sperti E; Faggiuolo R; Gerbino A; Magnino A; Muratore A; Ortega C; Ferraris R; Leone F; Capussotti L; Aglietta M
Dis Colon Rectum; 2006 Oct; 49(10):1596-601. PubMed ID: 16988853
[TBL] [Abstract][Full Text] [Related]
32. Liver resection for metastatic colorectal cancer in the age of neoadjuvant chemotherapy and bevacizumab.
Yoo PS; Lopez-Soler RI; Longo WE; Cha CH
Clin Colorectal Cancer; 2006 Sep; 6(3):202-7. PubMed ID: 17026789
[TBL] [Abstract][Full Text] [Related]
33. [Multimodal therapy for colon cancer: state of the art].
Weber T; Link KH
Zentralbl Chir; 2011 Aug; 136(4):325-33. PubMed ID: 21863510
[TBL] [Abstract][Full Text] [Related]
34. Survival outcomes of liver metastasectomy in colorectal cancer cases: a single-center analysis in Turkey.
Cokmert S; Ellidokuz H; Demir L; Fuzun M; Astarcioglu I; Aslan D; Yilmaz U; Oztop I
Asian Pac J Cancer Prev; 2014; 15(13):5195-200. PubMed ID: 25040974
[TBL] [Abstract][Full Text] [Related]
35. Metabolic response to preoperative chemotherapy predicts prognosis for patients undergoing surgical resection of colorectal cancer metastatic to the liver.
Lau LF; Williams DS; Lee ST; Scott AM; Christophi C; Muralidharan V
Ann Surg Oncol; 2014 Jul; 21(7):2420-8. PubMed ID: 24595797
[TBL] [Abstract][Full Text] [Related]
36. [Roles of hepatectomy for colorectal liver metastases with necrotic foci caused by prior anti-cancer therapies].
Ko S; Mukogawa T; Ishikawa H; Inoue T; Nishiwada T; Nakamoto T; Kunishige T; Watanabe A
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2569-72. PubMed ID: 21224642
[TBL] [Abstract][Full Text] [Related]
37. Targeted molecular therapies (cetuximab and bevacizumab) do not induce additional hepatotoxicity: preliminary results of a case-control study.
Pessaux P; Panaro F; Casnedi S; Zeca I; Marzano E; Bachellier P; Jaeck D; Chenard MP
Eur J Surg Oncol; 2010 Jun; 36(6):575-82. PubMed ID: 20452168
[TBL] [Abstract][Full Text] [Related]
38. Perioperative chemotherapy with or without bevacizumab in patients with metastatic colorectal cancer undergoing liver resection.
Constantinidou A; Cunningham D; Shurmahi F; Asghar U; Barbachano Y; Khan A; Mudan S; Rao S; Chau I
Clin Colorectal Cancer; 2013 Mar; 12(1):15-22. PubMed ID: 23021126
[TBL] [Abstract][Full Text] [Related]
39. Pathologic complete response to neoadjuvant FOLFOX in combination with bevacizumab in unresectable metastatic colorectal carcinoma.
Duffy A; Shia J; Huitzil-Melendez FD; Fong Y; O'Reilly EM
Clin Colorectal Cancer; 2008 Mar; 7(2):140-3. PubMed ID: 18501074
[TBL] [Abstract][Full Text] [Related]
40. "
Sánchez-Velázquez P; Moosmann N; Töpel I; Piso P
World J Gastroenterol; 2016 Dec; 22(46):10249-10253. PubMed ID: 28028374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]